Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.66)
# 853
Out of 4,707 analysts
377
Total ratings
52.6%
Success rate
17.3%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | 1,797p | +40.05% | 2 | May 26, 2026 | |
| SWX: CMHC Cosmo N.V. | Maintained: Buy | CHF 130.00 | CHF 55.70 | +133.39% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | CHF 80.00 | CHF 68.20 | +17.30% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Maintained: Buy | €5.00 | €5.80 | -13.79% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Maintained: Buy | €8.20 | €3.00 | +173.52% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | CHF 5.13 | -12.20% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Maintained: Buy | CHF 66.00 → CHF 73.00 | CHF 53.90 | +35.44% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €85.00 | €74.70 | +13.79% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Maintained: Buy | €33.00 | €20.60 | +60.19% | 51 | Apr 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 280.00 | kr 292.00 | -4.11% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 | €12.61 | +60.98% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €36.60 | €22.60 | +61.95% | 33 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €5.00 | €2.79 | +79.21% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.00 | €7.54 | +98.94% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €390.00 | €316.00 | n/a | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €0.80 → €0.64 | €0.07 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $48 | $27.63 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €79.00 → €41.00 | €24.08 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $397 → $436 | $1,007.07 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €342.00 → €375.00 | €869.20 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.56 | n/a | 3 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 57.00 | CHF 64.50 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | €2.80 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | €2.97 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €17.00 | €4.28 | n/a | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €0.60 → €0.40 | €0.71 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €2.70 | €0.38 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €3.93 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | €101.00 | n/a | 1 | Dec 21, 2022 |
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: 1,797p
Upside: +40.05%
Cosmo N.V.
May 11, 2026
Maintained: Buy
Price Target: CHF 130.00
Current: CHF 55.70
Upside: +133.39%
Sandoz Group AG
May 11, 2026
Maintained: Buy
Price Target: CHF 80.00
Current: CHF 68.20
Upside: +17.30%
Carvolix SA
May 4, 2026
Maintained: Buy
Price Target: €5.00
Current: €5.80
Upside: -13.79%
OSE Immunotherapeutics SA
Apr 30, 2026
Maintained: Buy
Price Target: €8.20
Current: €3.00
Upside: +173.52%
Idorsia Ltd
Apr 28, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: CHF 5.13
Upside: -12.20%
BB Biotech AG
Apr 24, 2026
Maintained: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: CHF 53.90
Upside: +35.44%
Sanofi
Apr 23, 2026
Maintained: Hold
Price Target: €85.00
Current: €74.70
Upside: +13.79%
Formycon AG
Apr 22, 2026
Maintained: Buy
Price Target: €33.00
Current: €20.60
Upside: +60.19%
Novo Nordisk A/S
Apr 20, 2026
Maintained: Hold
Price Target: kr 280.00
Current: kr 292.00
Upside: -4.11%
Apr 1, 2026
Maintained: Buy
Price Target: €20.30
Current: €12.61
Upside: +60.98%
Mar 6, 2026
Maintained: Buy
Price Target: €36.60
Current: €22.60
Upside: +61.95%
Feb 25, 2026
Maintained: Buy
Price Target: €5.00
Current: €2.79
Upside: +79.21%
Sep 25, 2025
Maintained: Hold
Price Target: €15.00
Current: €7.54
Upside: +98.94%
Jul 17, 2025
Maintained: Hold
Price Target: €390.00
Current: €316.00
Upside: n/a
May 6, 2024
Maintained: Sell
Price Target: €0.80 → €0.64
Current: €0.07
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $92 → $48
Current: $27.63
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: €79.00 → €41.00
Current: €24.08
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: $397 → $436
Current: $1,007.07
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: €342.00 → €375.00
Current: €869.20
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: $14
Current: $1.56
Upside: n/a
Nov 20, 2023
Maintained: Buy
Price Target: CHF 57.00
Current: CHF 64.50
Upside: n/a
Sep 7, 2023
Maintained: Buy
Price Target: €16.00
Current: €2.80
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: €2.97
Upside: n/a
Jun 22, 2023
Maintained: Buy
Price Target: €17.00
Current: €4.28
Upside: n/a
May 3, 2023
Maintained: Buy
Price Target: €0.60 → €0.40
Current: €0.71
Upside: n/a
Apr 28, 2023
Maintained: Buy
Price Target: €2.70
Current: €0.38
Upside: n/a
Dec 29, 2022
Maintained: Buy
Price Target: €12.00
Current: €3.93
Upside: n/a
Dec 21, 2022
Maintained: Buy
Price Target: €16.00
Current: €101.00
Upside: n/a